Altaroc
Newsroom
etc.
Private Equity
Special Report
Artificial Intelligence at the service of health
March 2024

Healthcare, a sector of focus forAltaroc

Published on
11/10/2023
Amended on
3/4/2024
0
minute(s)
Altaroc builds a global Private Equity Vintage every year, with an investment strategy diversified geographically (Europe, North America, Asia) and by sector (Tech, Telco, Digital Services, Digital Consumer, healthcare). Find out why healthcare is a key sector for Altaroc from Managing Partner Frédéric Stolar.
By
Damien Hélène
Damien Hélène
This article has been automatically translated. Please excuse any inaccuracies or translation errors.

Altaroc builds a Vintage global Private Equity portfolio every year. Its investment strategy is based on optimized diversification to build exceptional Vintage , with the following geographical breakdown:

  • 40% Europe,
  • 40% North America,
  • 20% Asia and rest of the world.

The breakdown is also sector-specific: 50% in Tech, Telco and Software, 20% in Digital Services, 10% in Digital Consumer and 20% in Healthcare.

Why has healthcare always been a key investment sector for Altaroc ? Frédéric Stolar, the firm's Managing Partner, explains.

in the spotlight

Artificial Intelligence at the service of health

New technologies are revolutionizing the healthcare sector more than ever. Artificial intelligence is now positioned as a diagnostic tool for certain cancers and cardiovascular diseases; it can also speed up clinical trials, predict potential complications linked to medical treatments and provide invaluable assistance with fertility. The managers of Vintage Altaroc have positioned themselves in this resilient, high-growth sector, which, as you will discover, offers the benefits of personalized, predictive medicine.
0
articles

The latest Hors-Séries

Special report N°7 - Nordic Capital

13
item(s)

Special report N°8 - Hg

14
item(s)

Special Summer 2024 feature

16
item(s)
Newsletter
Subscribe to our newsletter to keep up to date with all the latest news.
Artificial Intelligence at the service of health
North America
Europe
Rest of world
Healthcare